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INTRODUCTION
Mesenchymal stem cells (MSC) constitute a heterogeneous population found first in bone marrow (BM) and later in multiple tissues like adipose tissue, skin, cartilage, umbilical cord, placenta, and dental pulp [1] [2] [3] [4] [5] [6] . Although MSC from multiple sources share multiple cell surface antigens, they show different pluripotency in vitro depending of their source of origin [7] , which suggests that they could behave differently in vivo [8] .
Several studies reported the therapeutic benefits of injection of bone marrow-or adipose-derived MSC after myocardial infarction (MI) and other heart diseases [9 -12] . Transplantation of MSC resulted in improved ventricular function that was commonly associated with the induction of angiogenesis and myogenesis. To our knowledge, no studies have been performed to determine the therapeutic potential of dental pulp-derived MSC when they are transplanted after MI. Dental pulp stem cells (DPSC) were first described as MSClike odontogenic precursor cells with highly proliferative potential able to regenerate dentin in an immunocompromised host [6] . Although there are few reports comparing the antigenic features of DPSC and BM-MSC, cDNA microarray studies show that they differ in the expression of only a small number of genes [13, 14] . However, DPSC show higher self-renewal ability, immunomodulatory capacity, and proliferation in vitro than BM-MSC, and they differentiate preferentially to osteoblasts rather than to adipocytes [6, 15] . These cells, like BM-MSC, are able to secrete vascular endothelial growth factor (VEGF) [16 -18] , insulin-like growth factor-1 (IGF-1) and -2 (IGF-2) [13, 19, 20] , stem cell factor (SCF), and granulocytecolony stimulation factor [21, 22] , all of which can exert proangiogenic, antiapoptotic, and cardioprotective actions [3, 23, 24] . Thus, the aim of this study was to determine whether DPSC could be useful for cardiac repair, in a rat model of MI.
MATERIALS AND METHODS
All procedures were approved by the Instituto de Salud Carlos III and institutional ethical and animal care committees.
BM-MSC) to perform all the assays. The survival rate in all groups was 100%.
Cells, Culture Conditions, and Retroviral Transduction of DPSC
BM-MSC were purchased from Inbiomed (San Sebastian, Spain, http://www.inbiomed.org) and expanded following the manufacturer's instructions. Human dental pulp (n ϭ 3) was obtained from third molars, which were extracted for orthodontic reasons from healthy young people (18 -21 years of age) who gave their informed consent. The teeth were immediately cracked open, and the pulp tissue was removed and processed. Pulp was minced into small fragments (Ͻ1 mm 3 ) prior to digestion in a solution of 2 mg/ml collagenase type I (Gibco, Grand Island, NY, http://www. invitrogen.com) for 90 minutes at 37°C. After centrifugation, cells were seeded in culture flasks with growth medium (Dulbecco's modified Eagle's medium with low glucose supplemented with 10% fetal calf serum [Invitrogen] and antibiotics) in a humidified atmosphere of 95% air and 5% CO 2 at 37°C. Nonadherent cells were removed 48 hours after the initial plating. The medium was replaced every 3 days. When primary culture became subconfluent, after 10 -12 days, cells were collected by trypsinization and subcultured at 5,000 cells per cm 2 in growth medium. For enhanced green fluorescent protein (GFP) transduction, DPSC were seeded at 1,500 cells per cm 2 . To label the cells, supernatants containing retroviral eGFP particles obtained from the PG13-PSF-green fluorescent protein (GFP) packaging cell line were filtered through a 0.45-m filter, added to DPSC for 5 hours, and then replaced by fresh medium. This procedure was repeated daily for 3 days. Transduction efficiency was evaluated by flow cytometry. To assess the proliferative capacity of DPSC and GFP-DPSC, parallel cultures from three different donors were submitted to 12 serial passages. Population doublings (PD) were calculated using the formula PD ϭ [(log 10 (N H ) Ϫ log 10 (N 1 )]/log 10 (2), where N H is the cell harvest number and N 1 the inoculum cell number [7] . Cumulative population doublings were calculated, adding to each passage the PD of the previous passage. In vitro differentiation of DPSC to adipocytes or osteocytes was performed as previously described [15] .
Flow Cytometry
Human DPSC (passages [3] [4] [5] [6] [7] [8] [9] [10] 
Myocardial Infarction and Cell Transplantation
An animal model of myocardial infarction was conducted by ligation of the left coronary artery as previously described [25] . Rats were intubated and anesthetized (mixture of O 2 /Sevorane [Abbott Laboratories, Madrid, Spain, http://www.Abbott.es]; rate, 100 cycles per minute; tidal volume, 2.5 ml; small animal ventilator model 683 [Harvard Apparatus, Holliston, MA, http://www. harvardapparatus.com]), and after thoracotomy, the acute MI was induced by permanent ligation of the left descending coronary artery with 6-0 Prolene (Braun, Barcelona, Spain, http://www. braun.com). The infarcted area was visualized after ligation by development of a pale color in the distal myocardium. The incision was closed with a 3-0 silk suture, and Nolotil (Ingelheim, Germany, http://www.boehringer-ingelheim.es) (0.4 g/ml) was given intraperitoneally (0.5 ml/kg) as a pain palliative. Transplantation was performed in the subacute phase of MI [26] . Briefly, 7 days later, rats were anesthetized and reopened by a midline sternotomy to perform intramyocardial transplantation (10 6 GFP-DPSC or an 
Functional Assessment by Echocardiography
Rats were anesthetized with inhalatory anesthesia (Sevorane), the chest was shaved, and the rats were placed in the supine position. Transthoracic echocardiography was performed by a blinded echocardiographist using a General Electric system (Vivid 7; GE Healthcare, Little Chalfont, U.K., http://www.gehealthcare.com) equipped with a 10-MHz linear-array transducer. Measurements were taken at baseline (1 day preinfarction), postinfarction (7 days), and posttransplantation (2 and 4 weeks). M-Mode and two-dimensional (2D) echocardiography was performed at the level of the papillary muscles in the parasternal short axis view. Functional parameters over five consecutive cardiac cycles were calculated using standard methods [27] . 
Immunohistochemistry and Electron Microscopy
At 4 weeks postimplantation, animals were euthanized with an overdose of ketamine (125 mg/kg), valium (10 mg/kg), and atropine (50 mg/kg), and the hearts were removed, washed with phosphate-buffered saline, and fixed in 2% paraformaldehyde (PFA) or 2% PFA/glutaraldehyde for electron microscopy examination. The hearts were cryopreserved with 20% sucrose, embedded in Tissue-Tek OCT Compound (Sakura Finetek, Torrance, CA, http://www.sakura.com), and cut into 14-m slices. For electron microscopy studies, transverse sections of 50 m were cut on a cryostat. The sections were postfixed in 2% osmium for 2 hours, rinsed, rehydrated, and embedded in Araldite (Durcupan; Fluka Biochemica, Rokokoma, NY, http://www.sigmaaldrich. com). Serial 1.5-m semithin sections were cut with a diamond knife and stained with 1% toluidine blue. For identification of individual cells ultrathin (0.05 m) sections were cut with a diamond knife, stained with lead citrate, and examined under an FEI Tecnai spirit electron microscope (Hillsboro, OR, http://www. feicompany.com).
Vascular Density and Immunohistochemical Analysis
To detect newly formed vessels, rats from each group were euthanized at 4 weeks post-transplantation and examined via immunohistochemistry for expression of CD31 (Chemicon). Vessels were counted in 10 fields in the peri-infarct zone at a magnification of ϫ200. The number of vessels per unit area (mm 2 ) was determined using Image Pro Plus (version 5.1) to evaluate light micrographs.
Morphometry
The LV infarct size was measured in 8 -12 transverse sections of 14 m (one slice every 200 m of tissue from apex to base) stained with Masson's trichrome. The fibrotic zone was identified by the light blue color; scar area was determined by computer planimetry of the fibrotic regions using Image Pro Plus (version 5.1) software. All studies were performed in a blinded fashion. Infarct size was expressed as percentage of total left ventricular area and as a mean of all slices from each heart.
Statistical Analysis
Data are expressed as mean Ϯ SEM. Comparisons between MI and 4 weeks post-transplantation were performed with a paired Student t test. Comparisons of control and experimental groups were done with the Wilcoxon test. Statistical values were calculated using the SPSS software (SPSS, Chicago, http://www.spss.com). Differences were considered statistically significant at p Ͻ .05 with a 95% confidence interval.
RESULTS

Characterization and Retroviral Infection of Expanded Human DPSC
Dental pulp isolated from the pulp chamber (Fig. 1A) was digested, and cells were seeded in growth medium. At 1 week, adherent cells were detected (Fig. 1B) . Two weeks after plating, the adherent cells, covering 80% of the surface, were detached and seeded for further expansion and retroviral infection (for labeling with eGFP). As assessed by flow cytometry, DPSC constituted a homogeneous population, positive for CD29, CD44, CD90, CD105, and CD166; slightly positive for CD117 (Fig. 1C) ; and negative for CD14, CD34, CD45, CD106, and VEGFR-2 (not shown), indicating an MSC-like phenotype. Ultrastructural analysis showed lax chromatin, numerous cytoplasmic organules, rough endoplasmic reticulum, small Golgi apparatus, and filaments distributed along the cytoplasm (Fig. 1D,  arrows) . When DPSC were GFP-transduced, more than 50% of cells were labeled (Fig. 1E) ; after three to four rounds of infection, ϳ99% of cultured cells were GFP-positive (Fig. 1F) . Retroviral infection did not affect either their proliferation capacity (Fig. 1G) , the ability to transdifferentiate into adipocytes (Fig. 1H) and osteocytes (Fig. 1I) , or the surface antigen expression of DPSC as assessed by flow cytometry (passages 5-10; not shown).
DPSC Transplantation Improves Cardiac Function After Myocardial Infarction
The echocardiographic parameters from saline and DPSC groups are listed in Table 1 . At baseline and after MI, the values of the echocardiographic parameters analyzed were similar in treated and untreated animals, indicating comparable levels of tissue injury. In the saline group, there was a progressive significant deterioration of cardiac systolic function measured in terms of LV internal dimension (systole and diastole), EDA, and ESA (Table 1) .
DPSC treatment resulted in an improvement of all parameters measured 4 weeks post-transplantation versus MI values, whereas these changes were not appreciated in the saline group. The DPSC group showed an improvement in systolic function calculated in FAC (%): 42.9 Ϯ 2.9 versus 55.8 Ϯ 1.4; p Ͻ .02. In this group, there was also a significant increase in AWT (%), changing from 50.0 Ϯ 10.0 after MI to 78.3 Ϯ 10.1, 4 weeks after DPSC transplantation (p Ͻ .05). Wilcoxon test showed significant differences between saline and DPSC groups as soon as 2 weeks post-transplantation in the AWT (%), and FAC (%) parameters ( Fig. 2A, 2B ), which persisted along the time studied (4 weeks). To compare the effects of DPSC with those induced by the more extensively studied BM-MSC, a new group of animals transplanted with BM-MSC was included in the study as positive control (Fig. 2A, 2B) 
DPSC Do Not Differentiate into Cardiac or Smooth Muscle Cells
Analysis of cell engraftment was followed by the green epifluorescence of eGFP-DPSC. Human green cells were often located in the infarcted regions of tissue (Fig. 3A) . To assess whether DPSC maintained their original phenotypic pattern in vivo or they differentiate into cardiac or smooth muscle cells, cryopreserved heart tissue sections were analyzed by immunohistochemistry under the confocal microscope. One month after transplantation, engrafted GFP cells were all of human origin, as detected by human nuclei antibody (Fig. 3B) , and approximately 50% of engrafted cells still maintained the CD90 expression (Fig. 3C) . However, none of the human GFP cells detected were labeled with antibodies against cTnI (Fig. 3D) , atrial natriuretic peptide (Fig. 3E) , ␤-MHC (Fig. 3F), SMA (Fig. 3G) , or Myo D (Fig. 3H) , indicating that the transplanted cells did not differentiate into cardiac or smooth muscle cells. In addition, we did not find expression of endothelial markers or association of DPSC with the vascular network (data not shown). Engrafted DPSC maintained their ability to proliferate, as some GFP-DPSC positive for Ki67 staining were observed (Fig. 3I) . To further investigate DPSC differentiation, we performed immunogold staining followed by electron microscopy. DPSC were localized in the granulated tissue but not in the cardiomyocyte bundles (Fig. 3J) . Gold-labeled cells showed ultrastructure similar to that observed in (Fig. 1D) , with typical filaments along the cytoplasm (Fig.  3K, arrows) and the absence of sarcomeres, Z-line regions, or other cardiomyocyte-like structures, corroborating the lack of DPSC differentiation into cardiac cells.
Angiogenesis Induced by MSC
Vascular density was evaluated in the LV wall 30 days postimplantation by immunostaining with anti-CD31 antibody. The total number of vessels was significantly higher in the DPSC group than in the saline group (865.2 Ϯ 82.0 vs. 515.0 Ϯ 113.8; p Ͻ .05) (Fig. 4A) . These vessels were of rat origin; they contained blood cells, indicating their functionality (Fig. 4B) ; and they showed multiple caveolae, as analyzed by electron microscopy ( Fig. 4C) (the presence of multiple caveolae is related to the dynamic state of vascular cells).
DPSC Transplantation Reduces Infarcted Area
Cross-sections from DPSC and control animals were stained with Masson's trichrome and used to quantify the infarcted area in each animal. The area of fibrous scar tissue referred to as the total LV area was smaller in DPSC transplanted animals than in saline controls (15.9% Ϯ 1.7% vs. 21.2% Ϯ 1.6%; p Ͻ .05) (Fig. 5A) . Moreover, semithin sections of LV walls showed a significant increase in DPSC-treated animals (0.62 Ϯ 0.05 mm in control group vs. 1.26 Ϯ 0.21 mm in DPSC group; p Ͻ .05) (Fig. 5B) .
Organization of the Infarcted Tissue
To further investigate the morphological changes induced by DPSC transplantation, we obtained ultrathin sections of cardiac tissue from four animals of each group and analyzed the differences by electron microscopy. As can be seen in Figure 6 , analysis of ultrathin sections revealed bands of myocardial tissue disposed between the fibrotic layers only in the DPSC group; these bands were accompanied by an increase in the number of capillaries, as had been previously observed with the assays mentioned above. In addition, this higher resolution allowed us to visualize that cardiomyocyte bundles were healthy in the DPSC sections, probably because of the great number of vessels surrounding them, whereas they showed a notable degree of necrosis in control animals (not shown).
DISCUSSION
We demonstrate that DPSC constitute an alternative to BM-MSC in the armamentarium for cardiac repair. As true MSC, DPSC can survive and engraft in ischemic environments. The degree of restoration of cardiac function with DPSC transplantation was comparable to that observed with BM-MSC, and no significant differences were found between both groups. The improvement was especially noticeable in the percentage of AWT and FAC, indicating that DPSC transplantation not only prevents ventricular remodeling but also improves the regional contractility. Indeed, improvement in cardiac function was correlated with reduction of infarct size, higher capillary density, and increased wall thickness in DPSC-transplanted animals. In addition, ultrastructural analysis of LV wall peri-infarct zones showed an increase in cardiomyocyte bundles that reduced infarcted area and a higher proportion of myofibroblasts in the DPSC group (not shown). Myofibroblasts have been associated with the wound healing that occurs after ischemia, and their ontogenesis is related to the morphological changes observed in the fibroblasts when they are subjected to stress tension [28, 29] . Moreover, the onset of angiogenesis was closely correlated with repopulation of infarcted area with myofibroblasts in a mouse model of cardiomyopathy [30] . Thus, myofibroblasts could also account for the recovery of the LV tissue in DPSC group.
DPSC induced cardiac repair in the absence of cell differentiation. Although no specific experiments were performed to explore differentiation versus fusion, both phenomena were excluded since no expression of cardiac or smooth muscle markers was observed by confocal or electron microscopy analysis in GFP-transplanted cells. These results are in accordance with previous reports that support the ability of MSC to induce cardiac repair despite extremely rare fusion/differentiation events [10, [31] [32] [33] [34] [35] . However, we cannot rule out the possibility that longer periods of transplantation are necessary to induce the expression of cardiac markers in these cells, since allogeneic BM-MSC transplanted in the ischemic myocardium required between 3 and 6 months to express muscle markers [10] .
The data presented here suggest that the benefits observed after DPSC transplantation could be due to secretion of paracrine factors. In this context, adipose tissue-derived MSC, transplanted as a monolayer, increased wall thickness and improved cardiac function after myocardial infarction through secretion of hepatocyte growth factor and VEGF [31] . Moreover, using the c-kit mutant Kit W /Kit W-v mice, it has been demonstrated that BM-derived c-kit ϩ cells improved cardiac function by increasing VEGF and reversing the cardiac ratio of angiopoietin-1 to angiopoietin-2 [30, 36] . Regarding the possible factors involved in DPSC-mediated repair, one may speculate that VEGF could be one such factor, since secretion of VEGF in physiological amounts by DPSC is able to induce the formation of capillarylike networks in an ex vivo model of angiogenesis [18] . Considering that human DPSC have a level of gene expression similar to that of BM-MSC [13, 37] , it is also possible that other cytokines, such as IGF and SCF, secreted by DPSC could also contribute to the cardiac regeneration and improvement of LV function. Supporting this is the observation that these two cytokines show a cardioprotective effect when administered after MI [23, 38] . However, additional experiments should be performed to determine the possible factors responsible for this recovery.
CONCLUSION
DPSC are able to repair infarcted myocardium, and this is associated with an increase in the number of vessels and a reduction in infarct size, probably because of their ability to secrete proangiogenic and antiapoptotic factors. The degree of cardiac repair observed is similar to that obtained with BM-MSC. Therefore, this study extends the knowledge of DPSC therapeutical properties and provides a new source of stem cells for the treatment of ischemic diseases.
